Celebrating the discovery of mutated CALR
MPN Research Foundation is proud to celebrate the 10-year anniversary of the identification of CALR as a common driver of MPNs. We funded early work that discovered this MPN driver mutation. Learn more >
MPNRF by the numbers
Total donated dollars
invested in research
$ 0 M
Researchers supported
0
Countries with
supported research
0
Projects funded
0

What is
essential
thrombocythemia
(ET)
?

Essential Thrombocythemia (ET)

Most commonly diagnosed in women over the age of 50, ET is associated with a proliferation of platelet precursors in the bone marrow and complications frequently include blood clotting and/or bleeding.

Learn more about ET

What is
polycythemia vera
(PV)
?

Polycythemia vera (PV)

The disease is most common in men over the age of 60, but anyone can develop PV. PV patients typically experience an elevated red blood cell count, an elevated platelet count and an enlarged spleen, especially over time.

Learn more about PV

What is
myelofibrosis
(MF)
?

Myelofibrosis (MF)

MF is a chronic blood cancer in which excessive scar tissue forms in the bone marrow and impairs its ability to produce normal blood cells.

Learn more about MF
Patients, clinicians, researchers, and the biotech and pharma industries all have critical roles to play in advancing MPN research and are all important members of the MPNRF community.
Connect with us to be part of our coordinated effort to find new treatments — and eventually cures — for MPNs.

Patients
and Caregivers

Every patient experience is unique and provides new clues for researchers and clinicians.

Researchers
and
Clinicians

In our 24-year history, MPNRF has contributed to some of the most influential MPN research discoveries.

Industry
and
Biopharma

Engage with us to ensure that new therapies have the maximum impact on patient outcomes and quality of life.

Download our Voice of the Patient report

Ready to do more?

Julie and her family joined team MPN and created HikeMF to join the fight against MPNs.

Stay connected

Invest in MPN research

Your investment supports doctors and researchers around the world who are dedicated to finding cures for MPNs.

 INVEST NOW

Join the community
Be the first to know about the latest news and advancements for ET, PV, and MF. Sign up to receive our newsletters and alerts.

Recent news

  • October call out: Candy caution!

    MPN NEWS | October 28, 2024

    The sweet dilemma: balancing sugar intake and cancer risk this halloween Over the last 30 years, our consumption of sugar-laden beverages and processed foods has skyrocketed (Ma et al., 2022). While sugar itself isn’t inherently carcinogenic, the conditions it creates—like inflammation and metabolic dysfunction—set the stage for cancer to thrive.   Chronic inflammation plays a significant… Read More »October call out: Candy caution!

    READ MORE

    Dr. Robert Kralovics, PhD Research Profile

    MPN NEWS | October 25, 2024

    Profile: Dr. Robert Kralovics, PhDMedical University of Vienna Harnessing the Immune System: Dr. Robert Kralovics’ Groundbreaking MPN Research  Dr. Robert Kralovics is known for his relentless focus on unraveling the mysteries of myeloproliferative neoplasms (MPNs) —a family of rare blood cancers. As he admits, “I’ve been told I’m absent-minded because if someone suddenly talks to… Read More »Dr. Robert Kralovics, PhD Research Profile

    READ MORE

    Do you know your mutations? Genetics crossword

    MPN NEWS | October 4, 2024

    Do you know about mutations? Instructions:   New genes and proteins are being discovered every year in the landscape of MPN research. Put your genetic know-how to the ultimate test with this advanced-level MPN crossword puzzle. Answers may include gene acronyms, mutations, and numbers, but no hyphens. You can find these answers below.  Answers: Sources:   Guglielmelli, P.,… Read More »Do you know your mutations? Genetics crossword

    READ MORE